Page last updated: 2024-10-22

albuterol and Sarcoidosis

albuterol has been researched along with Sarcoidosis in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krzywiecki, A1
Ziora, D1
Oklek, K1
Niepsuj, G1
Kozielski, J1
PoloĊ„ska, A1

Trials

1 trial available for albuterol and Sarcoidosis

ArticleYear
[Effect of salbutamol inhalation on small airways function in patients with sarcoidosis].
    Pneumonologia i alergologia polska, 1995, Volume: 63, Issue:5-6

    Topics: Administration, Inhalation; Adult; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volum

1995